Editor’s Commentary

Abstract

Get full access to this article

View all access options for this article.

References

O’Brien

. Why ABPM should be mandatory in all trials of blood pressure-lowering drugs. Drug Information Journal. 2011;45:233–239.

Stockbridge

. ABPM part of FDA reviews. Drug Information Journal. 2011;45:567.

O’Brien

Turner

JR.

Assessing blood pressure responses to noncardiovascular drugs: the beneficial role of ambulatory blood pressure monitoring. Journal of Clinical Hypertension, in press. (DOI:10.1111/jch.12023)

Institute of Medicine. Knowing What Works in Healthcare: A Roadmap for the Nation. Washington, DC: National Academies Press.